Searched for
PFIZER SHARES GAIN
Pfizer CFO Dave Denton to leave company in AugustPfizer's finance chief Dave Denton is leaving on August 15. Cecile Guegan will be the interim chief financial officer. Denton's departure r...- Ahead of Market: 10 things that will decide stock market action on FridayIndian equities ended largely unchanged as West Asia tensions tempered risk appetite. Broader markets outperformed despite recent correctio...
- Why US stock market Dow Jones, S&P 500 and Nasdaq are surging big today: Dow jumps 350 points, Nasdaq jumps 250 points as Intel hits all-time high driving the rallyUS stock market surges today: why Dow Jones, S&P 500, and Nasdaq are rallying sharply despite global tensions? The Dow Jones Industrial Ave...
- Ahead of Market: 10 things that will decide D-Street action on MondayIndian equities saw a broad-based selloff on Friday, led by IT stocks, dragging benchmarks sharply lower. Nifty fell 1.14% and Sensex dropp...
- US Stocks | Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats upKailera Therapeutics shares surged 62.5% in their Nasdaq debut after raising $625 million in a U.S. IPO priced at the top end of its range....
- Pfizer shares gain 9% after Q3FY26 profit up 11%, revenue grows 20%Pfizer India's shares surged after reporting strong Q3FY26 results, with net profit up 11% and revenue by 20%. The company also recorded ex...
- Pfizer to acquire obesity drug startup Metsera in $10 billion dealPfizer has agreed to acquire obesity drug developer Metsera for up to $86.25 a share, surpassing Novo Nordisk's final offer. This move mark...
- Metsera accepts Pfizer's $10 billion bid in ongoing M&A battleMetsera has accepted Pfizer's $10 billion acquisition offer. This ends a bidding war with rival Novo Nordisk. Pfizer will pay $86.25 per sh...
- PFE stock rises 5.3% today: Pfizer seals Trump drug price deal with $70 billion U.S. investment and $7.3 billion Metsera weight-loss acquisitionPfizer Inc. (NYSE: PFE) experienced a significant uptick in its stock price following two major announcements on September 30, 2025. Presid...
- Pfizer PFE stock, Metsera MTSR stock: Pfizer, Metsera share prices jump as deal worth over $7 billion gets thumbs upStock Market boom for both companies' shares came as Pfizer said on Monday it would acquire drug developer Metsera in a deal valued at up t...
- Share market update: Pfizer, Artemis Medicare among top gainers on BSEAmong the 50 components in the Nifty index, 48 shares were trading in the green, while 2 were in the red.
- Pfizer shares gain over 3% as parent plans to buy HospiraShares of Pfizer rose by over 3 per cent as pharmaceuticals giant Pfizer Inc will acquire Hospira Inc, a leading provider of injectable dru...
- Pfizer, AstraZeneca shares climb up amidst deal talksThe two drugmakers declined to confirm the development, even as the news sent market punters to bet on the likely impact on its Indian subs...
- Pfizer, Wyeth merger to add more value to stocksIndian units of global drug majors Pfizer and Wyeth have been star performers on Dalal Street, notching up gains of nearly 55% and 60%, res...
- Pfizer to buy back $10 b in stock in line with its repurchase strategyThis is the fourth major share repurchase programme for New York-based company in past two-and-a-half years.
- Pfizer posts Q3 net profit at Rs 63.88 croreNet sales of the company stood at Rs 229.78 crore for the quarter under consideration against Rs 251.88 crore for the year-ago period.
- Strides settles up 8% after pact with PfizerStrides Arcolab on Thursday settled with a gain of little over 8 per cent at Rs 254.25 on the Bombay Stock Exchange.
- Wyeth to boost Pfizer's share in Indian marketPfizer's $68-billion buyout of Wyeth may help catapult its local subsidiary into the top ten league of Indian drugmakers.
- Ranbaxy shares rise on buzz of Pfizer 'counter-offer'The share price of Ranbaxy Laboratories rose to a 3-year high on Friday based on the rumour that the world’s largest drug maker, Pfizer, ma...
- Pfizer quashes Ranbaxy bid talks as 'rumours', shares soarWorld's biggest drugmaker Pfizer today termed as "rumours" talks about its interest in acquiring Indian pharma major Ranbaxy, even as share...
Load More
